Interactions of FK506 (tacrolimus) with clinically important drugs

Research Communications in Molecular Pathology and Pharmacology

Volumn 91, Issue 1, 1996, Pages 57-64

  Matsuda, Hiroji ^a   Iwasaki, Kazuhide ^a   Shiraga, Toshifumi ^a   Tozuka, Zenzaburo ^a   Hata, Takehisa ^a   Guengerich, F Peter ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CYCLOSPORIN A; CYTOCHROME P450; DICLOFENAC; INDOMETACIN; OMEPRAZOLE; PHENYLBUTAZONE; PREDNISOLONE; QUINIDINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SULINDAC; TACROLIMUS; THEOPHYLLINE;

AEROBIC METABOLISM; ARTICLE; CONCENTRATION RESPONSE; DRUG INHIBITION; DRUG METABOLISM; GRAFT REJECTION; HUMAN; HUMAN TISSUE; LIVER MICROSOME; OXIDATION; PRIORITY JOURNAL;

DRUG INTERACTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MICROSOMES, LIVER; PREDNISOLONE; TACROLIMUS; THEOPHYLLINE;

EID: 0030065812     PISSN: 00345164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Andersson, T., Miners, O.J., Verronese, E.M., and Birkett, J.D. (1994): Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism. Br. J. Clin. Pharmacol. 37: 597-604.
2. Guengerich, F.P. (1989): Characterization of human microsomal cytochrome P-450 enzymes. Ann. Rev. Pharmacol. Toxicol. 29: 241-264.
3. Guengerich, F.P., Müller-Enoch, D., and Blair, I.A. (1986): Oxidation of quinidine by human liver cytochrome P-450. Mol. Pharmacol. 30: 287-295.
4. Iwasaki, K., Matsuda, H., Nagase, K., Shiraga, T., Tokuma, Y., and Uchida, K. (1993): Effects of twenty-three drugs on the metabolism of FK506 by human liver microsomes. Res. Commun. Chem. Pathol. Pharmacol. 82: 209-216.
5. TB (CYP2C): A major monooxygenase catalyzing diclofenac 4′ -hydroxylation in human liver. Life Sci. 52: 29-34.
6. Lowry, O.H., Rosebrough, N.J., Parr, A.L., and Randall, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
7. Sarkar, A.M., Hunt, C., Guzelian, S.P. and Karnes H.T. (1992): Characterization of human liver cytochromes P-450 involved in theophylline metabolism. Drug Metab. Dispos. 20: 31-37.
8. Sattler, M., Guengerich, F.P., Yun, C., Christians, U. and Sewing, K. (1992): Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Drug Metab. Dispos. 20: 753-761.
9. Shiraga, T., Matsuda, H., Nagase, K., Iwasaki, K., Noda, K., Yamazaki, H., Shimada, T. and Funae, Y. (1994): Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P-450 3A enzymes in rat, dog and human liver microsomes. Biochem. Pharmacol. 47: 727-735.
10. Vincent, H.S., Karanam, V.B., Painter, K.S. and Chiu, L.S. (1992): In Vitro metabolism of FK-506 in rat, and human liver microsomes: identification of a major metabolite and of cytochrome P450 3A as the major enzymes responsible for its metabolism. Arch. Biochem. Biophys. 294: 454-460.
11. Waxman, J.D., Attisano, C., Guengerich, F.P. and Lapenson, P.D. (1988): Human liver microsomal steroid metabolism: Identification of the major microsomal steroid hormone 6β-hydroxylase cytochrome P-450 enzyme. Arch. Biochem. Biophys. 263: 424-436.
12. Yamazaki, H., Mimura, M., Oda, Y., Inui, Y., Shiraga, T., Iwasaki, K., Guengerich, F.P. and Shimada, T. (1993): Role of different forms of cytochrome P450 in the activation of the promutagen 6-aminochrysene to genotoxic metabolites in human liver microsomes. Carcinogenesis 14: 1271-1278.